SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Biagio Ricciuti, Giulia Costanza Leonardi, Giulio Metro, Francesco Grignani, Luca Paglialunga, Guido Bellezza, Sara Baglivo, Clelia Mencaroni, Alice Baldi, Daniela Zicari, Lucio Crinò, Targeting the KRAS variant for treatment of non-small cell lung cancer: potential therapeutic applications, Expert Review of Respiratory Medicine, 2016, 10, 1, 53

    CrossRef

  2. 2
    G. R. Blumenschein, E. F. Smit, D. Planchard, D.- W. Kim, J. Cadranel, T. De Pas, F. Dunphy, K. Udud, M.- J. Ahn, N. H. Hanna, J.- H. Kim, J. Mazieres, S.- W. Kim, P. Baas, E. Rappold, S. Redhu, A. Puski, F. S. Wu, P. A. Janne, A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC), Annals of Oncology, 2015, 26, 5, 894

    CrossRef

  3. 3
    Miranda B. Carper, Pier Paolo Claudio, Clinical potential of gene mutations in lung cancer, Clinical and Translational Medicine, 2015, 4, 1

    CrossRef

  4. 4
    Vijaya Raj Bhatt, Rishi Batra, Peter T. Silberstein, Fausto R. Loberiza, Apar Kishor Ganti, Effect of smoking on survival from non-small cell lung cancer: a retrospective Veterans’ Affairs Central Cancer Registry (VACCR) cohort analysis, Medical Oncology, 2015, 32, 1

    CrossRef

  5. 5
    Larry C. Frarey, Javier Martinez, Implications of Evolving Medical Science for Proof of Lung Cancer Causation, Beiträge zur Tabakforschung / Contributions to Tobacco Research, 2015, 26, 7

    CrossRef

  6. 6
    Helena A. Yu, Camelia S. Sima, Ronglai Shen, Samantha Kass, Justin Gainor, Alice Shaw, Megan Hames, Wade Iams, Jonathan Aston, Christine M. Lovly, Leora Horn, Christine Lydon, Geoffrey R. Oxnard, Mark G. Kris, Marc Ladanyi, Gregory J. Riely, Prognostic Impact of KRAS Mutation Subtypes in 677 Patients with Metastatic Lung Adenocarcinomas, Journal of Thoracic Oncology, 2015, 10, 3, 431

    CrossRef

  7. 7
    Zhibin Jiang, Jialiang Zhu, Yuchao Ma, Cao Hong, Sheng Xiao, Longyu Jin, Tyrosylprotein sulfotransferase�1 expression is negatively correlated with c-Met and lymph node metastasis in human lung cancer, Molecular Medicine Reports, 2015,

    CrossRef

  8. 8
    Giulio Metro, Rita Chiari, Chiara Bennati, Matteo Cenci, Biagio Ricciuti, Francesco Puma, Antonella Flacco, Alberto Rebonato, Diana Giannarelli, Vienna Ludovini, Guido Bellezza, Piero Ferolla, Vincenzo Minotti, Lucio Crinò, Clinical Outcome With Platinum-Based Chemotherapy in Patients With Advanced Nonsquamous EGFR Wild-Type Non–Small-Cell Lung Cancer Segregated According to KRAS Mutation Status, Clinical Lung Cancer, 2014, 15, 1, 86

    CrossRef

  9. 9
    Tiziana Vavalà, Matteo Giaj Levra, Silvia Novello, Lung cancer in never smokers: a different disease, Current Respiratory Care Reports, 2014, 3, 1, 26

    CrossRef

  10. 10
    Melissa L. Johnson, Camelia S. Sima, Jamie Chaft, Paul K. Paik, William Pao, Mark G. Kris, Marc Ladanyi, Gregory J. Riely, Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas, Cancer, 2013, 119, 2
  11. 11
    S Gahr, R Stoehr, E Geissinger, J H Ficker, W M Brueckl, A Gschwendtner, S Gattenloehner, F S Fuchs, C Schulz, R J Rieker, A Hartmann, P Ruemmele, W Dietmaier, EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice, British Journal of Cancer, 2013, 109, 7, 1821

    CrossRef

  12. 12
    J. Remon, E. Molina-Montes, M. Majem, P. Lianes, D. Isla, P. Garrido, E. Felip, N. Viñolas, J. de Castro, A. Artal, M.-J. Sánchez, Lung cancer in women: an overview with special focus on Spanish women, Clinical and Translational Oncology, 2013,

    CrossRef

  13. 13
    Daquan Meng, Mingli Yuan, Xiaojuan Li, Lijun Chen, Jie Yang, Xin Zhao, Wanli Ma, Jianbao Xin, Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: A systematic review with meta-analysis, Lung Cancer, 2013, 81, 1, 1

    CrossRef

  14. 14
    David E. Dawe, Peter M. Ellis, Challenges in Implementing Personalized Medicine for Lung Cancer within a National Healthcare System, Journal of Personalized Medicine, 2012, 2, 4, 77

    CrossRef

  15. 15
    Lauren Averett Byers, Molecular Profiling,